Sign Up to like & get
recommendations!
1
Published in 2019 at "Clinical Rheumatology"
DOI: 10.1007/s10067-019-04549-7
Abstract: The development of biologic agents, proteins engineered to specifically target key components of the inflammatory pathway, heralded a new era in the management of rheumatic diseases. With impressively high efficacy, especially in combination with methotrexate,…
read more here.
Keywords:
future consensus;
biosimilars americas;
consensus;
americas future ... See more keywords